Clinical trial

Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small…

NCT00008333 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00008333
Title Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Official title Oral Vinorelbine For The Treatment Of Metastatic Non-Small Cell Lung Cancer In Patients More Than Or Equal To 65 Years Of Age: A Phase II Trial of Efficacy and Patients Perceived Preference for Oral Therapy
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Lung Cancer
Intervention type Drug
Interventions vinorelbine tartrate
Enrollment 59
Start date Apr 1, 2001
Primary completion Mar 1, 2004
Completion Jul 1, 2007
First posted Feb 3, 2004
Last update posted Jul 13, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies